BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8836330)

  • 1. Differential efficacy of serotonergic drugs FG5974, FG5893, and amperozide in reducing alcohol drinking in P rats.
    Lankford MF; Björk AK; Myers RD
    Alcohol; 1996; 13(4):399-404. PubMed ID: 8836330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol intake in high alcohol drinking (HAD) rats is suppressed by FG5865, a novel 5-HT1A agonist/5-HT2 antagonist.
    Long TA; Kalmus GW; Björk A; Myers RD
    Pharmacol Biochem Behav; 1996 Jan; 53(1):33-40. PubMed ID: 8848457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring rats.
    Myers RD; Lankford MF; Björk A
    Pharmacol Biochem Behav; 1993 Jul; 45(3):741-7. PubMed ID: 8332634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol drinking in rats is attenuated by the mixed 5-HT1 agonist/5-HT2 antagonist FG 5893.
    Singh GK; Kalmus GW; Björk AK; Myers RD
    Alcohol; 1993; 10(3):243-8. PubMed ID: 8507395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of alcohol intake in diverse alcohol-preferring rat strains by the 5-HT2A antagonists amperozide and FG 5974.
    Overstreet DH; McArthur RA; Rezvani AH; Post C
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1448-54. PubMed ID: 9394117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide.
    Myers RD; Lankford M; Björk A
    Pharmacol Biochem Behav; 1992 Nov; 43(3):661-7. PubMed ID: 1448464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
    Myers RD; Lankford MF
    Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate and 5-HT2A receptors in alcohol drinking: preference in HAD rats is inhibited by combination treatment with naltrexone and amperozide.
    Lankford MF; Myers RD
    Alcohol; 1996; 13(1):53-7. PubMed ID: 8837935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
    Hjorth S; Pettersson G
    Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible suppression of alcohol drinking in cyanamide-treated rats after sustained delivery of the 5-HT2 antagonist amperozide.
    Myers RD; Lankford M; Björk A
    Alcohol; 1993; 10(2):117-25. PubMed ID: 8442888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mixed 5-HT 1A/2A receptor drug FG5938 suppresses alcohol drinking while enhancing feeding in P rats.
    Piercy KT; Björk AK; Myers RD
    Alcohol; 1996; 13(5):521-7. PubMed ID: 8888950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the action of the 5-HT2 antagonists amperozide and trazodone on preference for alcohol in rats.
    McMillen BA; Walter S; Williams HL; Myers RD
    Alcohol; 1994; 11(3):203-6. PubMed ID: 8060520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats.
    Biggs TA; Myers RD
    Pharmacol Biochem Behav; 1998 Jun; 60(2):407-13. PubMed ID: 9632223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats.
    McMillen BA; Jones EA; Hill LJ; Williams HL; Björk A; Myers RD
    Pharmacol Biochem Behav; 1993 Sep; 46(1):125-9. PubMed ID: 8255902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of the 5-HT2 receptor antagonist, ritanserin, to alter preference for alcohol in drinking rats.
    Myers RD; Lankford MF
    Pharmacol Biochem Behav; 1993 May; 45(1):233-7. PubMed ID: 8516364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of amperozide, 8-OH-DPAT, and FG 5974 on operant responding for ethanol.
    Roberts AJ; McArthur RA; Hull EE; Post C; Koob GF
    Psychopharmacology (Berl); 1998 May; 137(1):25-32. PubMed ID: 9631953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical pharmacology of FG5893: a potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors.
    Albinsson A; Björk A; Svartengren J; Klint T; Andersson G
    Eur J Pharmacol; 1994 Aug; 261(3):285-94. PubMed ID: 7813550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited access to ethanol in genetic drinking rats is suppressed while feeding is enhanced by the mixed 5-HT1A agonist/5-HT2A antagonist FG5938.
    West MW; Kalmus G; Myers RD
    Pharmacol Biochem Behav; 1998 Aug; 60(4):823-8. PubMed ID: 9700964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference.
    Meert TF
    Alcohol Alcohol; 1993 Mar; 28(2):157-70. PubMed ID: 8517886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.